Abi Vijenthira

TL;DR: Adult patients with hematologic malignancy and COVID-19, especially hospitalized patients, have a high risk of dying and adults aged ≥60 years have significantly higher mortality; pediatric patients appear to be relatively spared.

TL;DR: The authors were unable to cite all literature reports submitted to FAERS describing red cell morphology abnormalities and/or hemolytic anemia following exposure to alectinib.

TL;DR: Six predictors of admission to ICU were found in multivariable analysis, including disease-related (acute leukemia, curative intent chemotherapy, laboratory-related, albumin below normal, LDH above normal at time of admission), and physician-related factors (having advanced directives discussion) (p < 0.0001).

TL;DR: In this paper , the association of COVID-19 vaccination with breakthrough infections and complications in patients with cancer compared to non-cancer controls was determined, and the risk of SARS-CoV-2 breakthrough infection was highest for patients with hematologic cancer and any patients receiving active treatment.

TL;DR: Overall, the use of virtual care in patients with hematologic malignancies appears feasible, and resulted in high patient satisfaction, although further research is needed in order to evaluate the optimal method of integrating virtual care into clinical practice.